Destruction of retinal pigment epithelium, migration of black pigment, extreme narrowing of retinal vessels, optic disc pallor
Usually caused by hereditary disorders ("retinitis pigmentosa"), rarely by paraneoplastic or other autoimmune disorders, intra-uterine inflammatory, and acquired toxic-metabolic-neurodegenerative disorders
Two retinal areas are most vulnerable: mid-peripheral (equatorial) and perifoveal regions
Patient usually has constricted visual field and poor night vision ("nyctalopia")
Eventually foveal region itself becomes damaged and visual acuity fails
Genetically-determined retinopathies typically progress slowly
There is no treatment, but genetic counseling is important
Paraneoplastic retinopathy may progress faster, and there is controversy as to whether discovering underlying tumor or instituting immune-modulating treatment helps slow down visual loss, BUT earlier detection of tumor may improve survival
Autoimmune retinopathy may exist in isolation, but there is controversy about whether it is true entity and whether any form of treatment helps